CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Vitamin K2 (MK7)dietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02517580
NCT02517580Phase 2Completed
CompareCT.gov

Vitamin K2 Supplementation and Effect on Arterial Stiffness Progression in the Renal Transplant Population

Lebanese American University·interventional·Posted Aug 7, 2015·Updated Feb 9, 2018

In Brief

A Phase 2 clinical trial evaluating Vitamin K2 (MK7) for Arterial Stiffness and Vitamin K2 Deficiency. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This study is a single arm, single center clinical trial that aims to evaluate the effect of 8 weeks of vitamin K2 replacement (360 mcg/day) on the progression of arterial stiffness in stable renal transplant patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArterial Stiffness, Vitamin K2 Deficiency
CountriesLebanon
CollaboratorsOmicron Pharmaceuticals

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 7, 2015
Enrollment StartMar 1, 2015
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.9 years ago

Interventions

Vitamin K2 (MK7)dietary